Home
Who We Are
What We Do
Corporate Responsibility
News
Careers
Investors
Patients and HCPS
Contact us
Careers | Investors | Patients and HCPS | Contact us
Careers Investors Patients and HCPS Contact us
Commercialization
We aspire to commercialize products globally and to provide better therapies to diabetics globally.

Since 2005, we have developed a full range of diabetes treatment products such as glargine insulin injection, lispro insulin injection, aspart insulin injection, insulin delivery device, insulin injection needle, etc. in various countries and regions in the world, including the United States, Europe, Asia Pacific, Middle East, North Africa, Central and South America, CIS countries, and sub-Saharan Africa. At present, we have established global business networks in more than 20 countries and regions.

Latin American
SSA
MENA
Asia Pacific
China
CIS
Latin American
MENA
Asia Pacific
China
CIS
Europe
MENA
Asia Pacific
China
CIS
North America
CIS : Commonwealth of Independent States MENA : Middle Eastern & Northern Africa SSA : Sub-Saharan Africa
CIS : Commonwealth of Independent States MENA : Middle Eastern & Northern Africa
CIS : Commonwealth of Independent States MENA : Middle Eastern & Northern Africa
Copyright © 2021 Gan & Lee Pharmaceuticals Co Ltd . All Rights Reserved.
Our websites

Subscribe

I read, agree with and accept all of the Privacy Policy and Terms of Use of this website.